PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 20.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $86,000 | -19.6% | 14,500 | 0.0% | 0.05% | -23.9% |
| Q3 2017 | $107,000 | -69.1% | 14,500 | -71.6% | 0.07% | -70.0% |
| Q2 2017 | $346,000 | -28.1% | 51,000 | 0.0% | 0.24% | -29.7% |
| Q1 2017 | $481,000 | -33.7% | 51,000 | -51.4% | 0.34% | -46.6% |
| Q3 2016 | $726,000 | +56.8% | 105,000 | 0.0% | 0.63% | +48.1% |
| Q1 2016 | $463,000 | +32.7% | 105,000 | +75.0% | 0.43% | +27.2% |
| Q4 2015 | $349,000 | -18.6% | 60,000 | -20.0% | 0.34% | -24.0% |
| Q3 2015 | $429,000 | -25.8% | 75,000 | -3.2% | 0.44% | -8.5% |
| Q2 2015 | $578,000 | +20.9% | 77,500 | -3.1% | 0.48% | +17.3% |
| Q1 2015 | $478,000 | – | 80,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|